{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T11:48:21Z","timestamp":1792756101043,"version":"4.5.0"},"reference-count":40,"publisher":"BMJ","issue":"5","funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["JR16\/00006; MV17\/00021"],"award-info":[{"award-number":["JR16\/00006; MV17\/00021"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI15\/00061"],"award-info":[{"award-number":["PI15\/00061"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI15\/00587"],"award-info":[{"award-number":["PI15\/00587"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI17\/01228"],"award-info":[{"award-number":["PI17\/01228"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18\/01030"],"award-info":[{"award-number":["PI18\/01030"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI21\/01189"],"award-info":[{"award-number":["PI21\/01189"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008666","name":"Fundaci\u00f3 la Marat\u00f3 de TV3","doi-asserted-by":"publisher","award":["20142030"],"award-info":[{"award-number":["20142030"]}],"id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007747","name":"Red Espa\u00f1ola de Esclerosis M\u00faltiple","doi-asserted-by":"publisher","award":["RD16\/0015\/0002,"],"award-info":[{"award-number":["RD16\/0015\/0002,"]}],"id":[{"id":"10.13039\/501100007747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007747","name":"Red Espa\u00f1ola de Esclerosis M\u00faltiple","doi-asserted-by":"publisher","award":["RD16\/0015\/0003"],"award-info":[{"award-number":["RD16\/0015\/0003"]}],"id":[{"id":"10.13039\/501100007747","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"accepted":{"date-parts":[[2023,10,23]]},"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>We investigated the association between changes in retinal thickness and cognition in people with MS (PwMS), exploring the predictive value of optical coherence tomography (OCT) markers of neuroaxonal damage for global cognitive decline at different periods of disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>We quantified the peripapillary retinal nerve fibre (pRFNL) and ganglion cell-inner plexiform (GCIPL) layers thicknesses of 207 PwMS and performed neuropsychological evaluations. The cohort was divided based on disease duration (\u22645 years or &gt;5 years). We studied associations between changes in OCT and cognition over time, and assessed the risk of cognitive decline of a pRFNL\u226488 \u00b5m or GCIPL\u226477 \u00b5m and its predictive value.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Changes in pRFNL and GCIPL thickness over 3.2 years were associated with evolution of cognitive scores, in the entire cohort and in patients with more than 5 years of disease (p&lt;0.01). Changes in cognition were related to less use of disease-modifying drugs, but not OCT metrics in PwMS within 5 years of onset. A pRFNL\u226488 \u00b5m was associated with earlier cognitive disability (3.7 vs 9.9 years) and higher risk of cognitive deterioration (HR=1.64, p=0.022). A GCIPL\u226477 \u00b5m was not associated with a higher risk of cognitive decline, but a trend was observed at \u226491.5 \u00b5m in PwMS with longer disease (HR=1.81, p=0.061).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The progressive retinal thinning is related to cognitive decline, indicating that cognitive dysfunction is a late manifestation of accumulated neuroaxonal damage. Quantifying the pRFNL aids in identifying individuals at risk of cognitive dysfunction.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jnnp-2023-332332","type":"journal-article","created":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T13:22:15Z","timestamp":1700572935000},"page":"419-425","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Predictive value of retinal atrophy for cognitive decline across disease duration in multiple sclerosis"],"prefix":"10.1136","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1662-2317","authenticated-orcid":false,"given":"Salut","family":"Alba-Arbalat","sequence":"first","affiliation":[{"name":"Neuroimmunology and Multiple Sclerosis Unit, Hospital Clinic de Barcelona, Barcelona, Spain"},{"name":"Laboratory of Advanced Imaging in Neuroimmunological Diseases, Fundacio Recerca Clinic Barcelona -IDIBAPS, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Solana","sequence":"additional","affiliation":[{"name":"Neuroimmunology and Multiple Sclerosis Unit, Hospital Clinic de Barcelona, Barcelona, Spain"},{"name":"Laboratory of Advanced Imaging in Neuroimmunological Diseases, Fundacio Recerca Clinic Barcelona -IDIBAPS, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabet","family":"Lopez-Soley","sequence":"additional","affiliation":[{"name":"Neuroimmunology and Multiple Sclerosis Unit, Hospital Clinic de Barcelona, Barcelona, Spain"},{"name":"Laboratory of Advanced Imaging in Neuroimmunological Diseases, Fundacio Recerca Clinic Barcelona -IDIBAPS, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Camos-Carreras","sequence":"additional","affiliation":[{"name":"Ophthalmology Department, Hospital Clinic de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9937-3162","authenticated-orcid":false,"given":"Eloy","family":"Martinez-Heras","sequence":"additional","affiliation":[{"name":"Neuroimmunology and Multiple Sclerosis Unit, Hospital Clinic de Barcelona, Barcelona, Spain"},{"name":"Laboratory of Advanced Imaging in Neuroimmunological Diseases, Fundacio Recerca Clinic Barcelona -IDIBAPS, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Viv\u00f3","sequence":"additional","affiliation":[{"name":"Neuroimmunology and Multiple Sclerosis Unit, Hospital Clinic de Barcelona, Barcelona, Spain"},{"name":"Laboratory of Advanced Imaging in Neuroimmunological Diseases, Fundacio Recerca Clinic Barcelona -IDIBAPS, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Pulido-Valdeolivas","sequence":"additional","affiliation":[{"name":"Laboratory of Advanced Imaging in Neuroimmunological Diseases, Fundacio Recerca Clinic Barcelona -IDIBAPS, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magi","family":"Andorra","sequence":"additional","affiliation":[{"name":"Laboratory of Advanced Imaging in Neuroimmunological Diseases, Fundacio Recerca Clinic Barcelona -IDIBAPS, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Sepulveda","sequence":"additional","affiliation":[{"name":"Neuroimmunology and Multiple Sclerosis Unit, Hospital Clinic de Barcelona, Barcelona, Spain"},{"name":"Laboratory of Advanced Imaging in Neuroimmunological Diseases, Fundacio Recerca Clinic Barcelona -IDIBAPS, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Mar\u00eda","family":"Cabrera","sequence":"additional","affiliation":[{"name":"Neuroimmunology and Multiple Sclerosis Unit, Hospital Clinic de Barcelona, Barcelona, Spain"},{"name":"Laboratory of Advanced Imaging in Neuroimmunological Diseases, Fundacio Recerca Clinic Barcelona -IDIBAPS, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elianet","family":"Fonseca","sequence":"additional","affiliation":[{"name":"Laboratory of Advanced Imaging in Neuroimmunological Diseases, Fundacio Recerca Clinic Barcelona -IDIBAPS, Barcelona, Spain"},{"name":"Neurology Department, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1953-2803","authenticated-orcid":false,"given":"Alberto","family":"Calvi","sequence":"additional","affiliation":[{"name":"Neuroimmunology and Multiple Sclerosis Unit, Hospital Clinic de Barcelona, Barcelona, Spain"},{"name":"Laboratory of Advanced Imaging in Neuroimmunological Diseases, Fundacio Recerca Clinic Barcelona -IDIBAPS, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafel","family":"Alcubierre","sequence":"additional","affiliation":[{"name":"Ophthalmology Department, Hospital Clinic de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Dotti-Boada","sequence":"additional","affiliation":[{"name":"Ophthalmology Department, Hospital Clinic de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Saiz","sequence":"additional","affiliation":[{"name":"Neuroimmunology and Multiple Sclerosis Unit, Hospital Clinic de Barcelona, Barcelona, Spain"},{"name":"Laboratory of Advanced Imaging in Neuroimmunological Diseases, Fundacio Recerca Clinic Barcelona -IDIBAPS, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4272-0826","authenticated-orcid":false,"given":"Elena H","family":"Martinez-Lapiscina","sequence":"additional","affiliation":[{"name":"Laboratory of Advanced Imaging in Neuroimmunological Diseases, Fundacio Recerca Clinic Barcelona -IDIBAPS, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Villoslada","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Hospital del Mar Medical Research Institute, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"Blanco","sequence":"additional","affiliation":[{"name":"Neuroimmunology and Multiple Sclerosis Unit, Hospital Clinic de Barcelona, Barcelona, Spain"},{"name":"Laboratory of Advanced Imaging in Neuroimmunological Diseases, Fundacio Recerca Clinic Barcelona -IDIBAPS, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo","family":"Sanchez-Dalmau","sequence":"additional","affiliation":[{"name":"Ophthalmology Department, Hospital Clinic de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4273-9121","authenticated-orcid":false,"given":"Sara","family":"Llufriu","sequence":"additional","affiliation":[{"name":"Neuroimmunology and Multiple Sclerosis Unit, Hospital Clinic de Barcelona, Barcelona, Spain"},{"name":"Laboratory of Advanced Imaging in Neuroimmunological Diseases, Fundacio Recerca Clinic Barcelona -IDIBAPS, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,11,21]]},"reference":[{"key":"2026081401350929000_95.5.419.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200009283431307"},{"key":"2026081401350929000_95.5.419.2","doi-asserted-by":"publisher","DOI":"10.1191\/1352458506ms1258oa"},{"key":"2026081401350929000_95.5.419.3","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70259-X"},{"key":"2026081401350929000_95.5.419.4","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11111107","article-title":"Dynamics and predictors of cognitive impairment along the disease course in multiple sclerosis","volume":"11","author":"Lopez-Soley","year":"2021","journal-title":"J Pers Med"},{"key":"2026081401350929000_95.5.419.5","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1177\/1352458516682103","article-title":"Impairment of decision-making in multiple sclerosis: a neuroeconomic approach","volume":"23","author":"Sep\u00falveda","year":"2017","journal-title":"Mult Scler"},{"key":"2026081401350929000_95.5.419.6","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004977"},{"key":"2026081401350929000_95.5.419.7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071058","article-title":"Modeling of cognitive impairment by disease duration in multiple sclerosis: a cross-sectional study","volume":"8","author":"Achiron","year":"2013","journal-title":"PLoS One"},{"key":"2026081401350929000_95.5.419.8","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awy202"},{"key":"2026081401350929000_95.5.419.9","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.00147","article-title":"Cognitive impairment and brain reorganization in MS: underlying mechanisms and the role of neurorehabilitation","volume":"11","author":"Nasios","year":"2020","journal-title":"Front Neurol"},{"key":"2026081401350929000_95.5.419.10","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/134858","article-title":"The afferent visual pathway: designing a structural-functional paradigm of multiple sclerosis","volume":"2013","author":"Costello","year":"2013","journal-title":"ISRN Neurol"},{"key":"2026081401350929000_95.5.419.11","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24487"},{"key":"2026081401350929000_95.5.419.12","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-016-8127-y"},{"key":"2026081401350929000_95.5.419.13","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1002\/acn3.51473","article-title":"Optical coherence tomography in multiple sclerosis: a 3-year prospective multicenter study","volume":"8","author":"Paul","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"2026081401350929000_95.5.419.14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1001\/jamaneurol.2013.573","article-title":"Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis","volume":"70","author":"Saidha","year":"2013","journal-title":"JAMA Neurol"},{"key":"2026081401350929000_95.5.419.15","doi-asserted-by":"crossref","DOI":"10.1186\/1756-0500-7-910","article-title":"The multiple sclerosis visual pathway cohort: understanding neurodegeneration in MS","volume":"7","author":"Mart\u00ednez-Lapiscina","year":"2014","journal-title":"BMC Res Notes"},{"key":"2026081401350929000_95.5.419.16","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24030"},{"key":"2026081401350929000_95.5.419.17","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000200977"},{"key":"2026081401350929000_95.5.419.18","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-70255-z","article-title":"Retinal and brain damage during multiple sclerosis course: inflammatory activity is a key factor in the first 5 years","volume":"10","author":"Pulido-Valdeolivas","year":"2020","journal-title":"Sci Rep"},{"key":"2026081401350929000_95.5.419.19","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/1352458517694090","article-title":"Cognitive impairment in patients with multiple sclerosis is associated with atrophy of the inner retinal layers","volume":"24","author":"Coric","year":"2018","journal-title":"Mult Scler"},{"key":"2026081401350929000_95.5.419.20","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1007\/s00415-022-11449-5","article-title":"Optical coherence tomography (OCT) measurements and cognitive performance in multiple sclerosis: a systematic review and meta-analysis","volume":"270","author":"Mirmosayyeb","year":"2023","journal-title":"J Neurol"},{"key":"2026081401350929000_95.5.419.21","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(16)00068-5"},{"key":"2026081401350929000_95.5.419.22","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/1352458517740216","article-title":"Peripapillary retinal nerve fibre layer as measured by optical coherence tomography is a prognostic biomarker not only for physical but also for cognitive disability progression in multiple sclerosis","volume":"25","author":"Bsteh","year":"2019","journal-title":"Mult Scler"},{"key":"2026081401350929000_95.5.419.23","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1177\/1352458520935724","article-title":"Macular ganglion cell\u2013inner plexiform layer thinning as a biomarker of disability progression in relapsing multiple sclerosis","volume":"27","author":"Bsteh","year":"2021","journal-title":"Mult Scler"},{"key":"2026081401350929000_95.5.419.24","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30470-2"},{"key":"2026081401350929000_95.5.419.25","doi-asserted-by":"publisher","DOI":"10.1177\/1352458514542862"},{"key":"2026081401350929000_95.5.419.26","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.nicl.2016.11.026","article-title":"Structural networks involved in attention and executive functions in multiple sclerosis","volume":"13","author":"Llufriu","year":"2017","journal-title":"Neuroimage Clin"},{"key":"2026081401350929000_95.5.419.27","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13443"},{"key":"2026081401350929000_95.5.419.28","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.33.11.1444"},{"key":"2026081401350929000_95.5.419.29","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.41.5.685"},{"key":"2026081401350929000_95.5.419.30","doi-asserted-by":"publisher","DOI":"10.1177\/1352458517690821"},{"key":"2026081401350929000_95.5.419.31","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1985.01050120030015"},{"key":"2026081401350929000_95.5.419.32","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000003301","article-title":"The APOSTEL recommendations for reporting quantitative optical coherence tomography studies","volume":"87","author":"Cameron","year":"2016","journal-title":"Neurology"},{"key":"2026081401350929000_95.5.419.33","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000012125"},{"key":"2026081401350929000_95.5.419.34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034823","article-title":"The OSCAR-IB consensus criteria for retinal OCT quality assessment","volume":"7","author":"Tewarie","year":"2012","journal-title":"PLoS One"},{"key":"2026081401350929000_95.5.419.35","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3"},{"key":"2026081401350929000_95.5.419.36","doi-asserted-by":"crossref","first-page":"e2058","DOI":"10.1212\/WNL.0000000000011788","article-title":"Association of spectral-domain OCT with long-term disability worsening in multiple sclerosis","volume":"96","author":"Lambe","year":"2021","journal-title":"Neurology"},{"key":"2026081401350929000_95.5.419.37","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1212\/WNL.0000000000201223","article-title":"Preventing neurodegeneration in multiple sclerosis is required from the earliest stages of the disease","volume":"99","author":"Villoslada","year":"2022","journal-title":"Neurology"},{"key":"2026081401350929000_95.5.419.38","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.581700","article-title":"Impact of cognitive reserve and structural connectivity on cognitive performance in multiple sclerosis","volume":"11","author":"Lopez-Soley","year":"2020","journal-title":"Front Neurol"},{"key":"2026081401350929000_95.5.419.39","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/ene.13897","article-title":"Peripapillary retinal nerve fibre layer thinning rate as a biomarker discriminating stable and progressing relapsing-remitting multiple sclerosis","volume":"26","author":"Bsteh","year":"2019","journal-title":"Eur J Neurol"},{"key":"2026081401350929000_95.5.419.40","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1177\/13524585221097566","article-title":"Retinal layer thinning as a biomarker of long-term disability progression in multiple sclerosis","volume":"28","author":"Berek","year":"2022","journal-title":"Mult Scler"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2023-332332","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T09:37:21Z","timestamp":1786873041000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2023-332332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,21]]},"references-count":40,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,4,12]]},"published-print":{"date-parts":[[2024,5]]}},"alternative-id":["10.1136\/jnnp-2023-332332"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2023-332332","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,21]]}}}